Search

everythinglearnresearchcommunity

for

Search:↓

The document discusses challenges in eye care, including treating melanoma before macular hole repair, bloody tears resolved by blood pressure control, eyelash regrowth in hair-pulling disorder with medication, a non-invasive method to detect eyelash mites, and the psychological factors affecting contact lens comfort.

Various dermatology events and meetings were announced for 1998.

Auto-portraits help evaluate scalp hair.

Melatonin is important for skin health and protection, and can be made by the skin or applied to it.

Targeted cancer therapies often cause serious skin problems that need careful management.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Microneedling with 5% minoxidil improves hair loss in Chinese men by activating Wnt/ß-catenin pathway.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Low-dose oral minoxidil for hair loss can cause mild excessive hair growth, usually appearing within the first 3 months, but it can be managed by adjusting the dose or removing the unwanted hair, with most people not needing to stop the treatment.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Endocrine therapies for cancer significantly increase the risk of hair loss.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.